FOLH1 and prostate cancer: Along these lines, our group is currently evaluating the ability of 18F-radiohybrid (rh) PSMA-7.3 PET/MRI to detect higher risk disease among patients with low or favorable intermediate risk prostate cancer and Decipher Score ≥ 0.45.